Ibnsina Pharma (EGX:ISPH)
Egypt flag Egypt · Delayed Price · Currency is EGP
10.46
-0.04 (-0.38%)
At close: Mar 15, 2026

Ibnsina Pharma Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,54411,8147,0563,1652,4193,907
Market Cap Growth
70.08%67.43%122.93%30.83%-38.08%-20.04%
Enterprise Value
36,24135,43923,16815,14211,02010,960
Last Close Price
10.4611.726.903.102.133.23
PE Ratio
13.6715.3214.1718.2817.8413.65
Forward PE
7.698.7711.6210.443.909.83
PS Ratio
0.140.150.130.090.110.18
PB Ratio
3.794.243.472.181.922.69
P/TBV Ratio
4.144.643.892.571.972.72
P/OCF Ratio
---25.166.69-
PEG Ratio
-0.260.260.350.350.41
EV/Sales Ratio
0.470.460.420.450.500.50
EV/EBITDA Ratio
9.389.549.6911.9618.4813.97
EV/EBIT Ratio
10.2310.0110.2613.1522.8516.42
EV/FCF Ratio
-44.98-----
Debt / Equity Ratio
9.589.589.949.067.825.49
Debt / EBITDA Ratio
6.916.918.089.8314.829.47
Net Debt / Equity Ratio
9.239.239.538.287.395.17
Net Debt / EBITDA Ratio
6.926.928.109.4815.629.57
Net Debt / FCF Ratio
-31.90-31.90-16.31-52.59-21.33-15.39
Asset Turnover
2.362.362.372.161.842.12
Inventory Turnover
9.479.4710.5310.828.309.02
Quick Ratio
0.710.710.670.680.600.66
Current Ratio
1.021.021.001.001.001.03
Return on Equity (ROE)
39.54%39.54%35.32%15.75%12.60%22.31%
Return on Assets (ROA)
6.83%6.83%5.98%4.58%2.50%4.06%
Return on Invested Capital (ROIC)
11.46%12.55%11.32%7.63%4.81%5.87%
Return on Capital Employed (ROCE)
79.00%79.00%70.20%43.90%20.10%35.40%
Earnings Yield
7.31%8.06%8.71%6.75%7.13%8.05%
FCF Yield
-7.64%-6.82%-16.82%-7.21%-18.05%-12.49%
Dividend Yield
1.52%-2.32%--2.66%
Payout Ratio
21.12%21.12%4.17%10.74%81.35%4.63%
Buyback Yield / Dilution
----22.58%-16.25%
Total Shareholder Return
1.52%-2.32%-22.58%-13.59%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.